Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study journalArticle 2015 Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C.
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer journalArticle 2015 Deutsch, E.; Le Péchoux, C.; Faivre, L.; Rivera, S.; Tao, Y.; Pignon, J. P.; Angokai, M.; Bahleda, R.; Deandreis, D.; Angevin, E.; Hennequin, C.; Besse, B.; Levy, A.; Soria, J. C.
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status journalArticle 2015 Messai, Y.; Gad, S.; Noman, M. Z.; Le Teuff, G.; Couve, S.; Janji, B.; Kammerer, S. F.; Rioux-Leclerc, N.; Hasmim, M.; Ferlicot, S.; Baud, V.; Mejean, A.; Mole, D. R.; Richard, S.; Eggermont, A. M.; Albiges, L.; Mami-Chouaib, F.; Escudier, B.; Chouaib, S.
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study journalArticle 2015 Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends journalArticle 2015 Chouaid, C.; Borget, I.; Braun, E.; Bazil, M.; Schaetz, D.; Rémuzat, C.; Toumi, M.
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives journalArticle 2015 Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J.
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial journalArticle 2015 Salgado, R.; Denkert, C.; Campbell, C.; Savas, P.; Nuciforo, P.; Aura, C.; de Azambuja, E.; Eidtmann, H.; Ellis, C. E.; Baselga, J.; Piccart-Gebhart, M. J.; Michiels, S.; Bradbury, I.; Sotiriou, C.; Loi, S.
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours journalArticle 2015 Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X.
Long-term follow-up of TaG1 non-muscle-invasive bladder cancer journalArticle 2015 Olivier Bosset, P.; Neuzillet, Y.; Paoletti, X.; Molinie, V.; Botto, H.; Lebret, T.
Intramuscular administration of alfaxalone for sedation in rabbits journalArticle 2015 Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L.
Trends in tobacco-attributable mortality in France journalArticle 2015 Ribassin-Majed, L.; Hill, C.
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study journalArticle 2015 Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E.
Mortality analyses in the updated French cohort of uranium miners (1946-2007) journalArticle 2015 Rage, E.; Caer-Lorho, S.; Drubay, D.; Ancelet, S.; Laroche, P.; Laurier, D.
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival journalArticle 2015 Kapetanakis, N. I.; Uzan, C.; Jimenez-Pailhes, A. S.; Gouy, S.; Bentivegna, E.; Morice, P.; Caron, O.; Gourzones-Dmitriev, C.; Le Teuff, G.; Busson, P.
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases journalArticle 2015 de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J.
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models journalArticle 2015 Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.
Mineralogy and uranium leaching of ores from Triassic Peribaltic sandstones journalArticle 2015 Gajda, D.; Kiegiel, K.; Zakrzewska-Koltuniewicz, G.; Chajduk, E.; Bartosiewicz, I.; Wolkowicz, S.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort journalArticle 2015 Chougnet, C. N.; Borget, I.; Leboulleux, S.; de la Fouchardiere, C.; Bonichon, F.; Criniere, L.; Niccoli, P.; Bardet, S.; Schneegans, O.; Zanetta, S.; Schvartz, C.; Drui, D.; Chauffert, B.; Rohmer, V.; Schlumberger, M.
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement journalArticle 2015 Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review journalArticle 2015 Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours journalArticle 2015 Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X.
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection journalArticle 2015 Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M.
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma journalArticle 2015 Izzedine, H.; Derosa, L.; Le Teuff, G.; Albiges, L.; Escudier, B.
In reply to Alber and Sohn journalArticle 2015 Benadjaoud, M. A.; de Vathaire, F.; Blanchard, P.; Cardot, H.
A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer journalArticle 2015 Rondeau, V.; Pignon, J. P.; Michiels, S.; Group, Mach-Nc collaborative
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival journalArticle 2015 dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G.
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al journalArticle 2015 Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M.
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer journalArticle 2015 Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S.
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe journalArticle 2015 Bölling, T.; Braun-Munzinger, G.; Burdach, S.; Calaminus, G.; Craft, A.; Delattre, O.; Deley, M. C.; Dirksen, U.; Dockhorn-Dworniczak, B.; Dunst, J.; Engel, S.; Faldum, A.; Fröhlich, B.; Gadner, H.; Göbel, U.; Gosheger, G.; Hardes, J.; Hawkins, D. S.; Hjorth, L.; Hoffmann, C.; Kovar, H.; Kruseova, J.; Ladenstein, R.; Leuschner, I.; Lewis, I. J.; Oberlin, O.; Paulussen, M.; Potratz, J.; Ranft, A.; Rössig, C.; Rübe, C.; Sauer, R.; Schober, O.; Schuck, A.; Timmermann, B.; Tirode, F.; van den Berg, H.; van Valen, F.; Vieth, V.; Willich, N.; Winkelmann, W.; Whelan, J.; Womer, R. B.
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma journalArticle 2015 Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M.
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB] journalArticle 2015 Ezzalfani, M.; Dugue, A.; Mollevi, C.; Pulido, M.; Bonnetain, F.; Filleron, T.; Gal, J.; Gauthier, M.; Le Deley, M. C.; Le Tourneau, C.; Medioni, J.; Nguyen, J. M.; Chabaud, S.; Teixeira, L.; Thivat, E.; You, B.; Kramar, A.; Paoletti, X.
Design and statistical principles of the SHIVA trial journalArticle 2015 Paoletti, X.; Asselain, B.; Kamal, M.; Servant, N.; Huppe, P.; Bieche, I.; Le Tourneau, C.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review journalArticle 2015 Chouaïd, C.; Crequit, P.; Borget, I.; Vergnenegre, A.
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection journalArticle 2015 Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M.
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review journalArticle 2015 Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite journalArticle 2015 Grünewald, T. G.; Bernard, V.; Gilardi-Hebenstreit, P.; Raynal, V.; Surdez, D.; Aynaud, M. M.; Mirabeau, O.; Cidre-Aranaz, F.; Tirode, F.; Zaidi, S.; Perot, G.; Jonker, A. H.; Lucchesi, C.; Le Deley, M. C.; Oberlin, O.; Marec-Bérard, P.; Véron, A. S.; Reynaud, S.; Lapouble, E.; Boeva, V.; Rio Frio, T.; Alonso, J.; Bhatia, S.; Pierron, G.; Cancel-Tassin, G.; Cussenot, O.; Cox, D. G.; Morton, L. M.; Machiela, M. J.; Chanock, S. J.; Charnay, P.; Delattre, O.